Medistim ASA
SWB:MD1

Watchlist Manager
Medistim ASA Logo
Medistim ASA
SWB:MD1
Watchlist
Price: 22.1 EUR 3.76% Market Closed
Market Cap: €775.6m

Wall St Price Targets

MD1 Price Forecast
Based on 3 analysts

+40% Upside
from €22.1 today

MD1 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for MD1 yet.

Medistim ASA Competitors:
Price Targets

Revenue
Forecast

11% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 11%.

Gross Profit
Forecast

12% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

13% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
13% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 11%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
-31% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
13% / Year
Past Growth
-31% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 1 year is -31%.

Net Income
Forecast

14% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
14% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 8%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MD1's stock price target?
Price Target
30.88 EUR

According to Wall Street analysts, the average 1-year price target for MD1 is 30.88 EUR with a low forecast of 29.89 EUR and a high forecast of 32.51 EUR.

What is the Revenue forecast for Medistim ASA?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 11%.

What is the Gross Profit forecast for Medistim ASA?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Medistim ASA?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 11%.

What is the Pre-Tax Income forecast for Medistim ASA?
Projected CAGR
-31%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 1 year is -31%.

What is the Net Income forecast for Medistim ASA?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 8%.

Back to Top